EBT is found in 1 entry.

EBT as free ligands, exist in 1 entry. Example includes 3M50

Find related ligands: Stereoisomers Similar ligands Chemical Structure Search

View summary at Ligand Expo

Chemical Component Summary

Name N-[(2R,3R)-3-amino-2-hydroxy-4-phenylbutanoyl]-L-leucine
Identifiers (2S)-2-[[(2R,3R)-3-azanyl-2-hydroxy-4-phenyl-butanoyl]amino]-4-methyl-pentanoic acid
Formula C16 H24 N2 O4
Molecular Weight 308.373  g/mol
Isomeric SMILES CC(C)C[C@H](NC(=O)[C@H](O)[C@H](N)Cc1ccccc1)C(O)=O
InChI InChI=1S/C16H24N2O4/c1-10(2)8-13(16(21)22)18-15(20)14(19)12(17)9-11-6-4-3-5-7-11/h3-7,10,12-14,19H,8-9,17H2,1-2H3,(H,18,20)(H,21,22)/t12-,13+,14-/m1/s1

Chemical Details

Formal Charge 0
Atom Count 46
Chiral Atom Count 3
Chiral Atoms CA CAJ CAK
Bond Count 46
Aromatic Bond Count 6
Leaving Atoms n/a

Drug Info: DrugBank

DrugBank ID DB03424   (Different stereochemistry)
Name Bestatin
Groups experimental
Description Bestatin is a competitive protease inhibitor. It is an inhibitor of aminopeptidase B, leukotriene A4 hydrolase, aminopeptidase N. It is being studied for use in the treatment of acute myelocytic leukemia.
Synonyms Ubenimex
Brand Names Bestatin
Affected Organism Humans and other mammals
Indication An adjuvant therapy used for acute and chronic myelonous leukemia, lung cancer and nasopharyngeal cancer. It is also used to treat hypercholesterolaemia.
  • Antineoplastic Agents
  • Immunosuppressive Agents
  • Hypolipidemic Agents
CAS number 58970-76-6
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID: 21059682